Aged Care Insite Issue 114 | Oct-Nov 2019 | Page 18

industry & reform Would the pharmacists be working for the individual facilities? Onsite pharmacies Pharmacists should be embedded in aged care facilities, peak body says. Chris Freeman interviewed by Conor Burke T he Pharmaceutical Society of Australia is calling for a national program that would see pharmacists embedded in aged care facilities. A report by the PSA shows that 98 per cent of aged care residents have at least one medicine-related incident and 50 per cent are taking one inappropriate medicine. The PSA national president, Dr Chris Freeman, argues that regular access to pharmacists for residents and clinicians will help tackle medical mismanagement and related harm. “The health of the aged care sector matters a great deal to pharmacists, and many pharmacists already contribute to activities and services to improve resident safety and system changes impacting on quality and safety in aged care facilities,” he said. In a submission to the royal commission, the PSA also called for greater education for the aged care workforce, as well as residential medication management reviews. Freeman joined A ged Care Insite to discuss how embedding pharmacists in aged care would work. ACI: How affordable is it to have an onsite pharmacist? CF: A lot of the evidence being brought to the royal commission has focused on medicine management and the issues we are having in that sector. The reasons for that are multifactorial. From an affordability point of view, when the commission hands down its findings and recommendations, there’ll be some pressure on the government through the aged care division to look at ways of funding those recommendations being brought forward. We strongly support the government looking at funding some of those recommendations targeted towards medicine management. One of the ideas we have brought forward is pharmacists being integrated into those aged care settings. Now, what we’d expect to see would be a pharmacist in those settings, say, full-time. We expect that this is probably a part-time role across many of those settings, but we would see an injection of funding external to the aged care facilities themselves. 16 agedcareinsite.com.au Well, we’ve got over 32,000 pharmacists registered across Australia, so we have a ready and capable workforce. Of course, pharmacists are already engaged at a distance with aged care facilities, providing medicine reviews and quality use of medicine services. But what we don’t have is pharmacist time on the ground to assist residents and aged care staff to manage those medicines. The way we would see this rolled out would be a flexible model, knowing that the residential aged care sector has a very diverse model in which it operates. We wouldn’t expect a one-size-fits-all approach. We would expect a flexible approach where, on occasion, it might be a pharmacist directly engaged with a facility. In bigger aged care facilities, you might see a pharmacist engaged among a group of aged care facilities, particularly where those facilities might have a smaller number of beds, for example. The media has revealed that residents are being given antipsychotics for longer than the recommended periods, and that these drugs have little or even detrimental effects. What are you seeing in aged care currently that is allowing this to happen, and what needs to change? Again, the answer is multifactorial. We have an increasing population now moving into residential aged care, and we have an increasing burden of dementia and related diseases. We have had a period where there have been issues with workforce allocation into the aged care facilities, and unfortunately we see antipsychotics and sedatives in these facilities being used inappropriately for a number of those reasons. Particularly around, say, workforce, which are required to implement some of those non-drug strategies to assist patients with a behavioural disturbance related to their dementia. I think with our suggestion of integrating pharmacists into aged care, what we will see is more time on the ground for pharmacists in those facilities to help better protect patients from medicine-related harm, including those from antipsychotics and sedatives. We want pharmacists to be able to help doctors and GPs make the right decisions about the medicines at the time of prescribing. Certainly, at the moment, it’s a very reactive intervention, where the pharmacist often makes that recommendation to stop or withdraw that medicine after it’s already been implemented. At the royal commission, Dr Kathleen Sluggett of the PSA spoke about some of these issues, including polypharmacy, where people are taking nine or more drugs. If pharmacists are embedded in aged care, can they contravene the orders of a nurse or doctor ? What we would hope to see is that the pharmacist works very closely alongside the nursing staff and GPs. Of course, we’ve got an increasing scope of some nurses working in aged care, and we really see the role of the pharmacist as working alongside these prescribers. As people go through life, they will often develop a range of chronic diseases, and they tend to collect a lot of these medicines. Unfortunately, we don’t have a mechanism where we can comprehensively review over a long period of time that person’s medicine. What we’re asking is that the pharmacist be embedded to work alongside those other health professionals to provide support to them. One of the future models, potentially, might be that the pharmacist may have the ability to either step down that medicine, or stop it completely in a collaborative way, letting the GP and the nursing staff know as well. n